Mark E. Brooke‐Smith

ORCID: 0000-0003-4229-7773
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • COVID-19 and healthcare impacts
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Organ Transplantation Techniques and Outcomes
  • Gallbladder and Bile Duct Disorders
  • Pancreatitis Pathology and Treatment
  • Liver Disease and Transplantation
  • Cancer Genomics and Diagnostics
  • Gastrointestinal disorders and treatments
  • Trauma and Emergency Care Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Neuroendocrine Tumor Research Advances
  • Epigenetics and DNA Methylation
  • Liver Disease Diagnosis and Treatment
  • Cancer Cells and Metastasis
  • Colorectal Cancer Treatments and Studies
  • Abdominal Trauma and Injuries
  • Microbial metabolism and enzyme function
  • Surgical site infection prevention
  • Colorectal and Anal Carcinomas
  • Biliary and Gastrointestinal Fistulas
  • Nitric Oxide and Endothelin Effects
  • Ovarian cancer diagnosis and treatment
  • Hepatitis B Virus Studies

Flinders University
2002-2024

Flinders Medical Centre
2014-2024

University of Birmingham
2020-2022

Institut de Virologie
2020-2021

NIHR Birmingham Biomedical Research Centre
2021

Yorkshire Cancer Research
2021

Urology Foundation
2021

Association for Cancer Surgery
2021

AstraZeneca (Brazil)
2020

Stryker (United Kingdom)
2020

Claire Vennin Pauline Mélénec Romain Rouet Max Nobis Aurélie Cazet and 95 more Kendelle J. Murphy David Herrmann Daniel A. Reed Morghan C. Lucas Sean Warren Zehra Elgundi Mark Pinese Gabriella Kalna Daniel Roden Monisha Samuel Anaiis Zaratzian Shane T. Grey Andrew Da Silva Wilfred Leung Amber L. Johns Lorraine A. Chantrill Angela Chou Angela Steinmann Mehreen Arshi Tanya Dwarte Danielle Froio Brooke A. Pereira Shona Ritchie Cecilia R Chambers Xanthe Metcalf Nicola Waddell John V. Pearson Ann-Marie Patch Katia Nones Felicity Newell Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Conrad Leonard Scott Wood Sean M. Grimmond Oliver Hofmann Angelika N. Christ Timothy J. C. Bruxner Jaswinder S. Samra Nick Pavlakis Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David M. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Caroline Cooper Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Krishna Epari Mo Ballal David Fletcher Sanjay Mukhedkar Nikolajs Zeps Maria Beilin Kynan Feeney Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Rita T. Lawlor Stefania Beghelli Vincenzo Corbo Maria Scardoni Claudio Bassi

Abstract Heterogeneous subtypes of cancer-associated fibroblasts (CAFs) coexist within pancreatic cancer tissues and can both promote restrain disease progression. Here, we interrogate how cells harboring distinct alterations in p53 manipulate CAFs. We reveal the existence a p53-driven hierarchy, where with gain-of-function (GOF) mutant educate dominant population CAFs that establish pro-metastatic environment for GOF null alike. also demonstrate educated by may be reprogrammed either or...

10.1038/s41467-019-10968-6 article EN cc-by Nature Communications 2019-08-12
Vanessa Lakis Rita T. Lawlor Felicity Newell Ann‐Marie Patch Andrea Mafficini and 95 more Anguraj Sadanandam Lambros T. Koufariotis Rebecca L. Johnston Conrad Leonard Scott Wood Borislav C. Rusev Vincenzo Corbo Claudio Luchini Sara Cingarlini Luca Landoni Roberto Salvia Michèle Milella David K. Chang Peter J. Bailey Nigel B. Jamieson Fraser R. Duthie Marie‐Claude Gingras Donna M. Muzny David A. Wheeler Richard A. Gibbs Massimo Milione Lorraine A. Chantrill Paul Timpson Angela Chou Marina Pajic Angela Murphy Tanya Dwarte David Hermann Claire Vennin Thomas R. Cox Brooke A. Pereira Shona Ritchie Daniel A. Reed Cecilia R. Chambers Xanthe L. Metcalf Max Nobis Pamela Mukhopadhyay Venkateswar Addala Stephen H. Kazakoff Oliver Holmes Qinying Xu Oliver Hofmann Jaswinder S. Samra Nick Pavlakis Jennifer Arena Hilda High Ray Asghari Neil D. Merrett Darren Pavey Amitabha Das Peter H. Cosman Kasim Ismail Chelsie O’Connnor Alina Stoita David B. Williams Allan Spigellman Vincent Lam Duncan McLeod Judy Kirk James G. Kench Peter Grimison Charbel Sandroussi Annabel Goodwin R. Scott Mead Katherine Tucker Lesley Andrews Michael Texler Cindy Forest Mo Ballal David Fletcher Nikolajs Zeps Nan Q. Nguyen Andrew Ruszkiewicz Chris Worthley John Chen Mark E. Brooke‐Smith Virginia Papangelis Andrew D. Clouston Andrew P. Barbour Thomas O’Rourke Jonathan W. Fawcett Kellee Slater Michael Hatzifotis Peter Hodgkinson Mehrdad Nikfarjam James R. Eshleman Ralph H. Hruban Christopher L. Wolfgang Judith Dixon Maria Scardoni Claudio Bassi Sonia Grimaldi Cinzia Cantù Giada Bonizzato Samantha Bersani

Here we report the DNA methylation profile of 84 sporadic pancreatic neuroendocrine tumors (PanNETs) with associated clinical and genomic information. We identified three subgroups PanNETs, termed T1, T2 T3, distinct patterns methylation. The T1 subgroup was enriched for functional ATRX, DAXX MEN1 wild-type genotypes. contained mutations in recurrent chromosomal losses half genome no association between regions loss levels. were larger had lower MGMT gene body, which showed positive...

10.1038/s42003-020-01469-0 article EN cc-by Communications Biology 2021-02-03

Globally, there has been a concerning rise in the incidence of young-onset cancers. The aim this study was to provide trends and survival gastrointestinal adenocarcinomas (oesophagus, stomach, pancreas, colorectal) South Australia over 27-year period.This is cross-sectional analysis prospective longitudinal database including all cases prospectively reported Australian (State) Cancer Registry from 1990 2017.A total 28,566 patients diagnosed with oesophageal, pancreatic, or colorectal...

10.3390/cancers14020275 article EN Cancers 2022-01-06

Perianal sepsis is traditionally treated by incision and drainage, with packing of the residual cavity until healing. This study was designed to show that perianal abscess may be safely drainage alone.Healing times, analgesic requirements, pain scores, recurrence, fistula rates were compared between two randomized groups without cavities.Fifty patients recruited (7 lost follow-up): 20 in 23 nonpacking arm. The comparable terms age gender distribution, type size abscess, presence a at...

10.1007/s10350-004-0620-1 article EN Diseases of the Colon & Rectum 2004-07-09

Pancreatic cancer (PC) has the worst survival of all periampullary cancers. This may relate to histopathological differences between pancreatic cancers and other Our aim was examine distribution histopathologic features pancreatic, ampullary, biliary duodenal resected with a pancreaticoduodenectomy (PD) local trends PD.A retrospective review PD January 2000 December 2012 at public metropolitan database performed. The institutional ethics committee approved this study.There were 142 PDs...

10.1186/s12957-015-0498-5 article EN cc-by World Journal of Surgical Oncology 2015-01-01

Since the Coronavirus disease-19(COVID-19) pandemic, healthcare systems are reallocating their medical resources, with consequent narrowed access to elective surgery for benign conditions such as gallstone disease(GD). This survey represents an overview of current policies regarding surgical management patients GD during COVID-19 pandemic.A Web-based was conducted among 36 Hepato-Prancreato-Biliary surgeons from 14 Countries. Through a 17-item questionnaire, participants were asked about...

10.1016/j.amsu.2020.07.021 article EN Annals of Medicine and Surgery 2020-07-17

Liver resection (LR) and liver transplantation (LT) are two modalities offering potential for cure in patients with hepatocellular carcinoma (HCC). The objective of this study was to evaluate the long-term survival HCC treated LT LR analyse variables influencing these outcomes.Patients referred South Australian Transplant Unit Hepatopancreatobiliary at Flinders Medical Centre from January 1992 September 2009 a diagnosis who underwent or were included study. Histopathological parameters...

10.1111/j.1445-2197.2012.06196.x article EN ANZ Journal of Surgery 2012-09-03

Background: Expansion in liver transplantation (LT) criteria for HCC from Milan to UCSF has not adversely impacted overall survival, prompting further expansion towards Metroticket 2.0 (MT2). In this study, we compared patient survival post-transplant before and after 2007 long-term outcomes LT within versus (to determine the true benefit of criteria) retrospectively validated MT2 criteria. Methods: Retrospective analysis ANZLITR (including all patients transplanted since July 1997). The...

10.3390/cancers14112777 article EN Cancers 2022-06-03

Objectives: Acute pancreatitis is associated with compromised pancreatic microcirculation. Galanin a vasoactive neuropeptide, but its role in the regulation of vascular perfusion (PVP) unclear. Methods: Localization galanin immunoreactivity was investigated by immunohistochemistry, and effects bolus doses or antagonist galantide on blood pressure (BP) PVP (by laser Doppler fluxmetry) were determined anesthetized possums. Results: abundant possum pancreas particularly around vessels....

10.1097/mpa.0b013e31815ac561 article EN Pancreas 2008-04-01

Background . Autoimmune pancreatitis (AIP) often mimics pancreatic cancer. The diagnosis of both conditions is difficult preoperatively let alone when they coexist. Several reports have been published describing cancer in the setting AIP. Case Report case a 53-year-old man who presented with abdominal pain, jaundice, and radiological features autoimmune pancreatitis, “sausage-shaped” pancreas bulky head portal vein impingement, presented. He had normal serum IgG4 only mildly elevated...

10.1155/2013/809023 article EN cc-by Case Reports in Surgery 2013-01-01

The Wnt receptors ROR1 and ROR2 are generating increased interest as cancer therapeutic targets but remain understudied in pancreatic ductal adenocarcinoma (PDAC). Compared to canonical Wnt/ β-catenin signalling, the role of noncanonical signalling PDAC remains largely unknown. Only one study has investigated prognostic significance receptor, PDAC. No studies have PDAC.Here, we performed analysis mRNA expression three publicly available datasets ICGC-PACA-AU (n = 81), TCGA-PAAD 150)...

10.1186/s12885-021-08952-9 article EN cc-by BMC Cancer 2021-11-11

Abstract Patients with high model for end‐stage liver disease (MELD) scores waiting transplantation in Australia and New Zealand (ANZ) have had limited access to deceased donor livers therefore binational sharing of livers, patients a MELD score ≥35 was introduced February 2016. Waiting list mortality, post‐transplant outcomes intention‐to‐treat survival were compared between whose reached 35 on the October 2013 April 2015 (Pre‐Share group, n = 23) who Share listed 2016 May 2022 (Share 112)....

10.1111/ctr.15203 article EN cc-by-nc-nd Clinical Transplantation 2023-12-13

Inducible nitric oxide synthase (iNOS) plays a major role in acute pancreatitis. Selective inhibitors of iNOS are being developed as therapeutic agents. Sphincter Oddi (SO) dysfunction may cause pancreatitis and is necessary for SO relaxation. A new highly selective inhibitor, AR-C102222AA (AR-C), evaluated together with the established L-N(6)-(1-iminoethyl)lysine (L-NIL), neuronal (nNOS) blocker S-methyl-l-thiocitrulline (SMTC).In anaesthetized Australian Brush-tailed possums, effect...

10.1111/j.1365-201x.2004.01296.x article EN Acta Physiologica Scandinavica 2004-06-14
Coming Soon ...